BE812375A - 4'-alkyldioxyalkylene-5-benzylpyrimidines - Google Patents

4'-alkyldioxyalkylene-5-benzylpyrimidines

Info

Publication number
BE812375A
BE812375A BE142065A BE142065A BE812375A BE 812375 A BE812375 A BE 812375A BE 142065 A BE142065 A BE 142065A BE 142065 A BE142065 A BE 142065A BE 812375 A BE812375 A BE 812375A
Authority
BE
Belgium
Prior art keywords
alkyldioxyalkylene
benzylpyrimidines
Prior art date
Application number
BE142065A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19732313361 external-priority patent/DE2313361C3/de
Application filed filed Critical
Publication of BE812375A publication Critical patent/BE812375A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BE142065A 1973-03-17 1974-03-15 4'-alkyldioxyalkylene-5-benzylpyrimidines BE812375A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732313361 DE2313361C3 (de) 1973-03-17 2,4-Diamino-5-(3',5'-dimethoxy-4'-methoxyalkoxybenzyl-pyrimidine

Publications (1)

Publication Number Publication Date
BE812375A true BE812375A (fr) 1974-07-01

Family

ID=5875077

Family Applications (1)

Application Number Title Priority Date Filing Date
BE142065A BE812375A (fr) 1973-03-17 1974-03-15 4'-alkyldioxyalkylene-5-benzylpyrimidines

Country Status (16)

Country Link
US (1) US3992379A (fr)
JP (1) JPS584025B2 (fr)
AR (1) AR207561A1 (fr)
AT (1) AT338795B (fr)
AU (1) AU476979B2 (fr)
BE (1) BE812375A (fr)
BR (1) BR7401966D0 (fr)
CA (1) CA1063607A (fr)
CH (1) CH601257A5 (fr)
ES (1) ES424274A1 (fr)
FR (1) FR2221147B1 (fr)
GB (1) GB1413454A (fr)
HK (1) HK50580A (fr)
HU (1) HU166864B (fr)
IT (1) IT1060117B (fr)
NL (1) NL175414C (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115650A (en) * 1976-11-17 1978-09-19 Hoffmann-La Roche Inc. Process for preparing 2,4-diamino-5-(substituted benzyl)-pyrimidines
US4103902A (en) * 1977-08-16 1978-08-01 Foster Wheeler Energy Corporation Water seal for regenerator
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
DE3174994D1 (de) * 1980-11-27 1986-08-28 Wellcome Found Antibacterial benzylpyrimidines
JPS60107889U (ja) * 1983-12-20 1985-07-22 トキコ株式会社 給油量表示装置
DE3613794A1 (de) * 1986-04-24 1987-10-29 Frank Joachim Mueller Verfahren zum nachweis von antibiotika- und sulfonamidrueckstaenden in biologischen fluessigkeiten oder nahrungsmitteln

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909522A (en) * 1957-02-21 1959-10-20 Burroughs Wellcome Co Trialkoxybenzylpyrimidines and method
GB1142654A (en) * 1965-10-28 1969-02-12 Wellcome Found Cyano-acetals and their use in benzylpyrimidine synthesis
GB1229413A (fr) * 1967-06-14 1971-04-21
US3849407A (en) * 1969-03-06 1974-11-19 Burroughs Wellcome Co 5-benzyl pyrimidines intermediates
US3819629A (en) * 1970-02-10 1974-06-25 Burroughs Wellcome Co Method for preparing 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
US3692787A (en) * 1970-02-16 1972-09-19 Burroughs Wellcome Co Substituted 2,4-diamino-5-benzyl pyrimidines
US3772289A (en) * 1970-10-22 1973-11-13 Burroughs Wellcome Co Alkyl substituted benzyl pyrimidines

Also Published As

Publication number Publication date
HK50580A (en) 1980-09-12
DE2313361A1 (de) 1975-02-06
FR2221147B1 (fr) 1982-06-11
BR7401966D0 (pt) 1974-11-05
US3992379A (en) 1976-11-16
ATA215474A (de) 1977-01-15
JPS584025B2 (ja) 1983-01-24
CH601257A5 (fr) 1978-06-30
IT1060117B (it) 1982-07-10
HU166864B (fr) 1975-06-28
NL175414B (nl) 1984-06-01
AT338795B (de) 1977-09-12
ES424274A1 (es) 1976-11-01
AU6671374A (en) 1975-09-18
NL175414C (nl) 1984-11-01
FR2221147A1 (fr) 1974-10-11
NL7403411A (fr) 1974-09-19
CA1063607A (fr) 1979-10-02
GB1413454A (en) 1975-11-12
DE2313361B2 (de) 1975-07-10
JPS5035176A (fr) 1975-04-03
AR207561A1 (es) 1976-10-15
AU476979B2 (en) 1976-10-07

Similar Documents

Publication Publication Date Title
AT328981B (de) Sequestrierungsmittel
AT351454B (de) Verbundstein
DK136525C (da) Herbicidt virksomme halogenerede 4-trifluormethyl-4'-nitro-diphenylethere
DK140348C (da) Forskalling
HU171552B (hu) Snegovaja cep' protiv buksovki
HU171789B (hu) Sposob poluchenija 3,6,8-zamehhonnykh s-triazolo-skobka-4,3-b-skobka zakryta-piridazinov
ATA797073A (de) Stoffloeserstoffloeser22140973
HU172808B (hu) Sposob i ustrojstvo dlja otdelenija ammiaka ot otrabotannogo vozdukha svetokopiroval'nykh apparatov
HU172775B (hu) Krivolinejnaja shpil'ka dlja skreplenija kostej
BE811489A (fr) Phenoxyalcanecarboxylates d'hydroxyalkyltheophyllines
HU171769B (hu) Sposob poluchenija lechebnykh preparatov soderzhahhikh n-/2-furfuril/-4-khlor-5-sul'famoil-antranilovoj kisloty s vytjanutym ehffektom
RO66809A (fr) Trenail d'etayement
HU173856B (hu) Ehlement dlja kreplenija stroitel'nykh blokov k stenam i podobnym chastjam zdanij
TR18175A (tr) Sugutucu'ar-dondurucular
BE817599A (fr) 8alpha-oestratrienes 1
BE820275A (fr) Polysulfures d'alkyl-etain-thioesters
HU171874B (hu) Sposob poluchenija proizvodnykh 5,6-benzo-gamma-pirona
IT1050244B (it) 2 1 3 benzotiadiazin 4 one 2 2 biossidi
BE811714A (fr) N(1
HU173870B (hu) Predokhranitel'nyj mekhanizm k ustrojstvu dlja vstrelivanija krepjozhnykh ehlementov
HU170991B (hu) Sposob poluchenija 2-/geterociklicheskikh-metil'nykh/ proizvodnykh morfolina
BE818710A (fr) Benzodioxoles 2
BE811610R (fr) D-6-methyl-ergolines 2
BE819944A (fr) N'(aminoacylaminophenyl)-acetamidines
BE815063A (fr) 4'-deshydro-oleandrine

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: LUDWIG HEUMANN & CO. G.M.B.H.

Effective date: 19940315